Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aravind Ramakrishnan

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
ASN Neuro|July 8, 2017
Modulation of Hematopoietic Lineage Specification Impacts TREM2 Expression in Microglia-Like Cells Derived From Human Stem CellsPeter J Amos, Susan Fung, Amanda Case, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2016
Reductive carboxylation is a major metabolic pathway in the retinal pigment epitheliumJianhai Du, Aya Yanagida, Kaitlen Knight, et al.
Nature Cancer|January 6, 2026
Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trialPaolo Strati, Lori Leslie, Parveen Shiraz, et al.
Blood|July 7, 2012
Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDSH Joachim Deeg, Bart L Scott, Min Fang, et al.
Blood Advances|October 17, 2024
Access barriers to anti-CD19+ CART therapy for NHL across a community transplant and cellular therapy networkMinoo Battiwalla, Michael Tees, Ian Flinn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 21, 2014
Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemiaBoglarka Gyurkocza, Jonathan Gutman, Eneida R Nemecek, et al.
Experimental Eye Research|December 20, 2021
Extracellular matrix dysfunction in Sorsby patient-derived retinal pigment epitheliumAbbi L Engel, YeKai Wang, Thomas H Khuu, et al.
Clinical Hematology International|October 17, 2024
Determinants of Outcomes for Acute Myeloid Leukemia Patients Treated in a Community-Based Specialized Versus Non-Specialized Hospital SettingMinoo Battiwalla, Ju-Hsien Chao, Tonya Cox, et al.
Transplantation and Cellular Therapy|March 23, 2025
Comparative Efficacy of Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion Before Chimeric Antigen Receptor T-Cell Therapy in LymphomaUttam K Rao, Navneet S Majhail, Betsy Blunk, et al.
Nature Communications|November 24, 2025
T<sub>SCM</sub>-predominant allogeneic anti-BCMA CAR-T therapy for relapsed/refractory multiple myeloma: preclinical characterization and interim results from a phase 1 trialHubert Tseng, Bhagirathbhai Dholaria, Stacey A Cranert, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
ASN Neuro|July 8, 2017
Modulation of Hematopoietic Lineage Specification Impacts TREM2 Expression in Microglia-Like Cells Derived From Human Stem CellsPeter J Amos, Susan Fung, Amanda Case, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2016
Reductive carboxylation is a major metabolic pathway in the retinal pigment epitheliumJianhai Du, Aya Yanagida, Kaitlen Knight, et al.
Nature Cancer|January 6, 2026
Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trialPaolo Strati, Lori Leslie, Parveen Shiraz, et al.
Blood|July 7, 2012
Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDSH Joachim Deeg, Bart L Scott, Min Fang, et al.
Blood Advances|October 17, 2024
Access barriers to anti-CD19+ CART therapy for NHL across a community transplant and cellular therapy networkMinoo Battiwalla, Michael Tees, Ian Flinn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 21, 2014
Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemiaBoglarka Gyurkocza, Jonathan Gutman, Eneida R Nemecek, et al.
Experimental Eye Research|December 20, 2021
Extracellular matrix dysfunction in Sorsby patient-derived retinal pigment epitheliumAbbi L Engel, YeKai Wang, Thomas H Khuu, et al.
Clinical Hematology International|October 17, 2024
Determinants of Outcomes for Acute Myeloid Leukemia Patients Treated in a Community-Based Specialized Versus Non-Specialized Hospital SettingMinoo Battiwalla, Ju-Hsien Chao, Tonya Cox, et al.
Transplantation and Cellular Therapy|March 23, 2025
Comparative Efficacy of Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion Before Chimeric Antigen Receptor T-Cell Therapy in LymphomaUttam K Rao, Navneet S Majhail, Betsy Blunk, et al.
Nature Communications|November 24, 2025
T<sub>SCM</sub>-predominant allogeneic anti-BCMA CAR-T therapy for relapsed/refractory multiple myeloma: preclinical characterization and interim results from a phase 1 trialHubert Tseng, Bhagirathbhai Dholaria, Stacey A Cranert, et al.
Pageof 4